| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfe5d59fd6b14c02afc38a0af2583c78 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5403 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 |
| filingDate |
1992-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afb6b6ca710f91094afaefe684fd4f6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42d67041468f88e8b19a2e947a0bf890
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c95004c3865fa019ae3d1285222ac6c2 |
| publicationDate |
1993-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2120707-A1 |
| titleOfInvention |
Human il-3 variants |
| abstract |
Human IL-3 variants or mutants are characterised in that one or more amino acids in or adjacent to the fourth predicted .alpha.-helix of hIL-3 and/or one or more amino acids in the first predicted .alpha.-helix of hIL-3 is/are replaced by another amino acid. These variants or mutants are useful in the modulation of profileration, differentiation or functional activation of haemopoietic cells or non-haemopoietic cells expressing or made to express the IL-3 receptor. |
| priorityDate |
1991-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |